Clinical Trial

Weizmannia Coagulans BC99 Relieves Exercise-induced Fatigue

Completed
View on ClinicalTrials.gov →
Summary
To evaluate the clinical effects of Weizmannia coagulans BC99 supplementation compared with placebo on plasma amino acid profiles in male university students following a 12-week intervention.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-24.
Trial Details
NCT Number NCT07325422
Lead Sponsor Wecare Probiotics Co., Ltd.
Conditions College Student
Enrollment 72 participants
Start Date 2023-11-01
Primary Completion 2024-03-12 (estimated)
Study Completion 2024-03-30 (estimated)
Updated on ClinicalTrials.gov 2026-01-09